These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26156739)
1. Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial. Lin X; Qi Q; Zheng Y; Huang T; Lathrop M; Zelenika D; Bray GA; Sacks FM; Liang L; Qi L Am J Clin Nutr; 2015 Aug; 102(2):514-9. PubMed ID: 26156739 [TBL] [Abstract][Full Text] [Related]
2. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial. Heianza Y; Ma W; Huang T; Wang T; Zheng Y; Smith SR; Bray GA; Sacks FM; Qi L Diabetes Care; 2016 Nov; 39(11):1909-1914. PubMed ID: 27581055 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Zhang X; Qi Q; Liang J; Hu FB; Sacks FM; Qi L Hypertension; 2012 Nov; 60(5):1169-75. PubMed ID: 22966009 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism of neuropeptide Y gene rs16147 modifies the response to a hypocaloric diet on cardiovascular risk biomarkers and adipokines. de Luis DA; Izaola O; de la Fuente B; Primo D; Aller R J Hum Nutr Diet; 2017 Apr; 30(2):159-165. PubMed ID: 27599771 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of intrapericardial and extrapericardial fat tissues during long-term, dietary-induced, moderate weight loss. Tsaban G; Wolak A; Avni-Hassid H; Gepner Y; Shelef I; Henkin Y; Schwarzfuchs D; Cohen N; Bril N; Rein M; Serfaty D; Kenigsbuch S; Tene L; Zelicha H; Yaskolka-Meir A; Komy O; Bilitzky A; Chassidim Y; Ceglarek U; Stumvoll M; Blüher M; Thiery J; Dicker D; Rudich A; Stampfer MJ; Shai I Am J Clin Nutr; 2017 Oct; 106(4):984-995. PubMed ID: 28814394 [No Abstract] [Full Text] [Related]
6. Greater Healthful Dietary Variety Is Associated with Greater 2-Year Changes in Weight and Adiposity in the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. Vadiveloo M; Sacks FM; Champagne CM; Bray GA; Mattei J J Nutr; 2016 Aug; 146(8):1552-9. PubMed ID: 27358422 [TBL] [Abstract][Full Text] [Related]
7. Polymorphism rs16147 of the Neuropeptide Y Gene Modifies the Response of Cardiovascular Risk Biomarkers and Adipokines to Two Hypocaloric Diets. de Luis DA; Izaola O; Primo D; Aller R J Nutrigenet Nutrigenomics; 2017; 10(1-2):63-72. PubMed ID: 28787737 [TBL] [Abstract][Full Text] [Related]
8. Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: a randomized controlled trial. Veum VL; Laupsa-Borge J; Eng Ø; Rostrup E; Larsen TH; Nordrehaug JE; Nygård OK; Sagen JV; Gudbrandsen OA; Dankel SN; Mellgren G Am J Clin Nutr; 2017 Jan; 105(1):85-99. PubMed ID: 27903520 [TBL] [Abstract][Full Text] [Related]
9. A Common Variant of NGEF Is Associated with Abdominal Visceral Fat in Korean Men. Kim HJ; Park JH; Lee S; Son HY; Hwang J; Chae J; Yun JM; Kwon H; Kim JI; Cho B PLoS One; 2015; 10(9):e0137564. PubMed ID: 26340433 [TBL] [Abstract][Full Text] [Related]
10. The FTO genotype as a useful predictor of body weight maintenance: initial data from a 5-year follow-up study. Matsuo T; Nakata Y; Hotta K; Tanaka K Metabolism; 2014 Jul; 63(7):912-7. PubMed ID: 24798613 [TBL] [Abstract][Full Text] [Related]
11. Is abdominal obesity at baseline influencing weight changes in observational studies and during weight loss interventions? Svendstrup M; Allin KH; Ängquist L; Schnohr P; Jensen GB; Linneberg A; Thuesen B; Astrup A; Saris WHM; Vestergaard H; Sørensen TIA Am J Clin Nutr; 2018 Nov; 108(5):913-921. PubMed ID: 30475965 [TBL] [Abstract][Full Text] [Related]
12. Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity. Zheng Y; Huang T; Zhang X; Rood J; Bray GA; Sacks FM; Qi L J Nutr; 2015 May; 145(5):977-82. PubMed ID: 25761503 [TBL] [Abstract][Full Text] [Related]
13. [Effect of a Mediterranean-pattern diet on the metabolic response secondary to weight loss; role of the single nucleotide polymorphism (rs16147) of neuropeptide Y]. Primo Martín D; Izaola Jáuregui O; López Gómez JJ; Gómez Hoyos E; Ortolá Buigues A; Delgado E; Díaz G; Torres Torres B; de Luis Román DA Nutr Hosp; 2020 Aug; 37(4):742-749. PubMed ID: 32686440 [TBL] [Abstract][Full Text] [Related]
14. Changes of Branched-Chain Amino Acids and Ectopic Fat in Response to Weight-loss Diets: the POUNDS Lost Trial. Li X; Sun D; Zhou T; Ma H; Heianza Y; Liang Z; Bray GA; Sacks FM; Qi L J Clin Endocrinol Metab; 2020 Oct; 105(10):e3747-56. PubMed ID: 32561903 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohorts. Yeung EH; Zhang C; Chen J; Bowers K; Hu FB; Kang G; Qi L J Clin Endocrinol Metab; 2011 Dec; 96(12):E2055-62. PubMed ID: 21937627 [TBL] [Abstract][Full Text] [Related]
16. Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women. Mutschler J; Abbruzzese E; Wiedemann K; von der Goltz C; Dinter C; Mobascher A; Thiele H; Diaz-Lacava A; Dahmen N; Gallinat J; Majic T; Petrovsky N; Thuerauf N; Kornhuber J; Gründer G; Rademacher L; Brinkmeyer J; Wienker T; Wagner M; Winterer G; Kiefer F Ann Nutr Metab; 2013; 62(4):271-6. PubMed ID: 23652383 [TBL] [Abstract][Full Text] [Related]
17. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Zhang X; Qi Q; Zhang C; Smith SR; Hu FB; Sacks FM; Bray GA; Qi L Diabetes; 2012 Nov; 61(11):3005-11. PubMed ID: 22891219 [TBL] [Abstract][Full Text] [Related]
18. Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity. de Luis DA; Izaola O; de la Fuente B; Primo D; Aller R J Nutrigenet Nutrigenomics; 2016; 9(5-6):213-221. PubMed ID: 27788523 [TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity and inflammatory bowel disease. Rowan CR; McManus J; Boland K; O'Toole A Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989 [TBL] [Abstract][Full Text] [Related]
20. DNA Methylation at ABCG1 and Long-term Changes in Adiposity and Fat Distribution in Response to Dietary Interventions: The POUNDS Lost Trial. Li X; Shao X; Kou M; Wang X; Ma H; Grundberg E; Bazzano LA; Smith SR; Bray GA; Sacks FM; Qi L Diabetes Care; 2023 Dec; 46(12):2201-2207. PubMed ID: 37770056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]